Regulation of CD28 Costimulation in Human CD8+ T Cells

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1551-1558

  Lloyd, Thomas E ^a   Yang, Lixia ^a   Tang, Derek Ng ^a   Bennett, Tellen ^a   Schober, Wendy ^a   Lewis, Dorothy E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELL CULTURE; DOWN REGULATION; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 0031568527     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. June, C. H., J. A. Ledbetter, T. Lindsten, and C. B. Thompson. 1989. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes. J. Immunol. 143:153.
2. Harding, F. A., J. A. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1995. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
3. Bluestone, J. A. 1995, New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
4. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991b. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
5. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
6. Linsley, P. S., J. Bradshaw, M. Urnes, L. Grosmaire, and J. A. Ledbetter. 1993. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J. Immunol. 150:3161.
7. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989b. An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cells proliferation and prevent the induction of unresponsiveness. J. Immunol. 142:2617.
8. Tan, P., C. Anasetti, J. A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J. A. Ledbetter, and P. S. Linsley. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165.
9. Chen, C., and N. Nabavi, 1994. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1:147.
10. Landay, A. L. C. E. Mackewicz, and J. A. Levy. 1993. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:106.
11. + T lymphocytes during HIV-1 infection. AIDS 7:245.
12. + cells in HIV infection. J. Immunol. 153: 412.
13. Brinchmann, J. E., J. H. Dobloug, B. H. Heger, L. L. Haaheim, M. Sannes, and T. Egeland. 1994. Expression of costimulatory molecule CD28 on T cells in HIV infection: functional and clinical correlations. J Infect. Dis. 169:730.
14. + T cells. Clin. Exp. Immunol. 100:425.
15. + subset. J. Immunol. 154:6182.
16. + counterparts. J. Immunol. 156:3587.
17. - precursors by differentiation occurring in late immune responses. Eur. J. Immunol. 24:1503.
18. - T ceils. AIDS 8:431.
19. - T lymphocytes: antigenic and functional properties. J. Immunol. 150:1147.
20. + TC1 cells; loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med. 182:1505.
21. Lake, R. A., R. E. O'Hehir, A. Verhoef, and J. R. Lamb. 1993. CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide. Int. Immunol. 5:461.
22. Ciobanu, N., K. Weite, G. Kruger, S. Venuta, J. Gold, S. P. Feldman, C. Y., Wang, B. Koziner, M. A. S. Moore, B. Safai, and R. Mertelsmann. 1983. Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2. J. Clin. Immunol. 3:332.
23. Lane, H. C., J. M. Depper, W. C. Greene, G. Whalen, T. A. Waldmann, and A. S. Fauci. 1985. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 313:79.
24. Clerici, M., F. T. Hakim, D. J. Venzon, S. Blatt, C. W. Hendrix, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759.
25. Hyjek, E., H. W. Lischner, T. Hyslop, J. Bartkowiak, M. Kubin, G. Trinchieri, and D. Kozbor. 1955. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J. Immunol. 155:4060.
26. H2 predominance in HIV-infected individuals. Science 265:248.
27. H0 cells. Science 265:244.
28. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180:489.
29. H2 cytokines and help B cells. Science 260:1802.
30. Shindo, T., K. Sugie, K. Nakamura, Y. Tagaya, M. Maeda, T. Uchiyama, K. Sagawa, M. Yokoyama, H. Wada, S. Hitomi, and J. Yodoi. 1990. Downregulation of KOLT-2 antigen (CD28) by interleukin 2: role of TL-2R (p70). Immunology 71:63.
31. + T cell clones: implication from functional significance of CD8-β. Int. Immunol. 3:737.
32. Armitage, R. J., A. E. Namen, H. M. Sassenfeld, and K. H. Grabstein. 1990. Regulation of human T cell proliferation by IL-7. J. Immunol. 144:938.
33. Shahinian, A., k. Pfeffer, K. p. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
34. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
35. Lucas, P. J., I. Negishi, K.-I. Nakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol 154:5757.
36. Kay, J. E., L. Kromwel, S. E. A. Doe, and M. Denyer. 1991. Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology 72:544.
37. Bierer, B. E., S. L. Schreiber, and S. J. Burakoff. 1991. The effect of the immnosuppressant FK-506 on alternate pathways of T cell activation. Eur. J. Immunol. 21:439.
38. Kuo, C. J., J. Chung, D. F. Fiorentino, W. M. Flanagan, J. Blenis, and G. R. Crabtree. 1992. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358:70.
39. Terada, N., K. Takase, P. Papst, A. C. Nairn, and E. W. Gelfand. 1995. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes. J. Immunol. 155:3418.
40. Schwarz, E. M., P. Salgame, and B. R. Bloom. 1993. Molecular regulation of human interleukin 2 and T-cell function by interleukin 4. Proc. Natl. Acad Sci. USA 90:7734.
41. Donnelly, R. P., L. J. Crofford, S. L. Freeman, J. Buras, E. Remmers, R. L. Wilder, and M. J. Fenton. 1993. Tissue-specific regulation of IL-6 production by IL-4. J. Immunol. 151:5603.
42. Lee, K. P., C. Taylor, B. Petryniak, L. A. Turka, C. H. June, and C. B. Thompson. 1990. The genomic organization of the CD28 gene: implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol. 145:344.
43. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S.-I. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627.
44. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1995 Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313.
45. Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587.
46. Krowka, J., D. Stites, J. Mills, H. Hollander, T. McHugh, M. Busch, L. Wilhelm, and L. Blackwood. 1988. Effects of interleukin 2 and large envelope glycoprotein (gp120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses ,o cytomegalovirus. Clin. Exp. Immunol. 72:179.
47. Lifson, J. D., C. J. Benike, D. F. Mark, K. Koths, and E. G. Engleman. 1984. Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS. Lancet II:698.
48. + T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 87:2379.